Okay, let's tackle this question about bronchopulmonary aspergillosis. The user wants me to explain why the correct answer is right and the others are wrong. First, I need to recall the key points about this condition.

Bronchopulmonary aspergillosis (BPA) is a hypersensitivity reaction to Aspergillus species, typically in patients with asthma or cystic fibrosis. The main types are allergic bronchopulmonary aspergillosis (ABPA) and aspergilloma. The question is asking which statement is not true, so I need to identify the exception among the options.

The core concept here is understanding the different forms of aspergillosis and their clinical features. The correct answer is likely an option that confuses ABPA with other forms like aspergilloma or invasive aspergillosis. For example, if an option states that ABPA is caused by invasive growth, that would be incorrect because ABPA is a hypersensitivity reaction, not invasive.

Now, considering the wrong options, they might include statements about treatment, diagnostic criteria, or associations. For instance, an incorrect option might claim that ABPA is common in immunocompromised patients, but actually, invasive aspergillosis is more common in those with weakened immune systems. Another wrong option could be about the presence of central cavities in ABPA, which are more typical of aspergilloma.

The clinical pearl here is to remember that ABPA is a hypersensitivity condition in underlying lung diseases, and its treatment involves corticosteroids and antifungals. The high-yield fact is distinguishing ABPA from other aspergillosis forms based on clinical context and response to treatment.

**Core Concept**
Bronchopulmonary aspergillosis (BPA) is a hypersensitivity reaction to *Aspergillus* species, primarily occurring in patients with asthma or cystic fibrosis. It includes allergic bronchopulmonary aspergillosis (ABPA) and aspergilloma, distinct from invasive aspergillosis which affects immunocompromised hosts.

**Why the Correct Answer is Right**
The false statement likely describes **invasive aspergillosis** (e.g., "caused by invasive fungal growth in immunocompetent hosts") rather than BPA. BPA is characterized by **Type I and III hypersensitivity reactions**, with features like eosinophilia, central bronchiectasis, and precipitating antibodies to *Aspergillus*. Invasive aspergillosis, in contrast, involves **acute fungal invasion** of angioinvasive tissue and occurs in neutropenic or immunosuppressed patients.

**Why Each Wrong Option is Incorrect**
**Option A:** *If it claims BPA is common in immunocompromised patients* – Incorrect. BPA occurs in **non-immunocompromised** individuals with pre-existing airway disease (e.g., asthma).
**Option B:** *If it states ABPA is diagnosed via sputum culture* – Incorrect. Diagnosis relies on **serology** (IgE), clinical criteria, and imaging, not culture.
**Option C:** *If it mentions "central cavitary lesions" as diagnostic* – Incorrect. Central bronchiectasis is a hallmark of

✓ Correct Answer: B. Pleural effusion